NCT07676058 Comparative Effects of Myofascial Release and Instrument Assisted Soft Tissue Moblization in Pregnant Women With Plantar Fasciitis
| NCT ID | NCT07676058 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Lahore |
| Condition | Plantar Fasciitis |
| Study Type | INTERVENTIONAL |
| Enrollment | 44 participants |
| Start Date | 2026-06-30 |
| Primary Completion | 2026-07-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 44 participants in total. It began in 2026-06-30 with a primary completion date of 2026-07-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Plantar fasciitis is a common musculoskeletal disorder characterized by heel pain and functional limitations, which may become more pronounced during pregnancy due to weight gain, hormonal changes, and altered biomechanics. Conservative physiotherapy interventions are commonly used to manage symptoms; however, evidence regarding the comparative effectiveness of different manual therapy techniques in pregnant women remains limited. This randomized clinical trial aims to compare the effects of Myofascial Release (MFR) and Instrument-Assisted Soft Tissue Mobilization (IASTM) on pain intensity and foot function in pregnant women diagnosed with plantar fasciitis. A total of 44 pregnant women aged 20-40 years in their second or third trimester will be recruited and randomly allocated into two treatment groups. Both groups will receive baseline treatment consisting of therapeutic ultrasound, gastrocnemius and soleus stretching exercises, tibialis anterior strengthening, and a home exercise program. In addition, Group A will receive Myofascial Release, while Group B will receive Instrument-Assisted Soft Tissue Mobilization. The intervention will be delivered over a period of four weeks, with three supervised sessions per week. Pain intensity will be assessed using the Numerical Pain Rating Scale (NPRS), while foot-related pain, disability, and functional limitations will be measured using the Foot Function Index (FFI). Outcomes will be evaluated at baseline and after completion of the intervention. The findings of this study are expected to provide evidence regarding the most effective manual therapy approach for reducing pain and improving functional outcomes in pregnant women suffering from plantar fasciitis.
Eligibility Criteria
Inclusion Criteria: * Pregnant women aged 20-40 years. * In the second and third trimester of pregnancy (gestational weeks 12-34). * Clinically diagnosed with plantar fasciitis, with symptoms of heel pain at the medial calcaneal insertion of the plantar fascia. * The pain is most intense with the first few steps in the morning or after prolonged rest. Positive findings from a Windlass test or palpation-provoked pain indicating plantar fasciitis. Exclusion Criteria: * Known foot fractures or significant foot deformities. * Systemic inflammatory diseases (e.g., rheumatoid arthritis) that may affect tissue healing and response to therapy. * Active obstetric complications that contraindicate physiotherapy. * Recent corticosteroid injections to the heel (\<6 months prior). * Inability or unwillingness to comply with follow-up visits or the intervention protocol.
Contact & Investigator
Fatima Altaf, MSPTWH
PRINCIPAL INVESTIGATOR
The University of Lahore, Lahore
Frequently Asked Questions
Who can join the NCT07676058 clinical trial?
This trial is open to female participants only, aged 20 Years or older, up to 40 Years, studying Plantar Fasciitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07676058 currently recruiting?
Yes, NCT07676058 is actively recruiting participants. Contact the research team at fatimaaltaf24@yahoo.com for enrollment information.
Where is the NCT07676058 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT07676058 clinical trial?
NCT07676058 is sponsored by University of Lahore. The principal investigator is Fatima Altaf, MSPTWH at The University of Lahore, Lahore. The trial plans to enroll 44 participants.